Stephen Berezenko

Former Vice President-Protein Manufacturing at Cerenis Therapeutics Holding SA

Stephen Berezenko

Stephen Berezenko

Former Vice President-Protein Manufacturing at Cerenis Therapeutics Holding SA

Biography

Dr. Stephen Berezenko is Vice President-Protein Manufacturing at Cerenis Therapeutics Holding SA.Dr. Berezenko was previously employed as Research Director by Novozymes Biopharma AU Ltd.

Overview
RelSci Relationships

20

Relationships
RelSci Relationships are individuals Stephen Berezenko likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Finance Officer & Secretary at Novozymes Biopharma AU Ltd.

Relationship likelihood: Average

Former Chief Executive Officer at Photonz Corp. Ltd.

Relationship likelihood: Average

Former Senior Director-Biology at Cerenis Therapeutics Holding SA

Relationship likelihood: Weak

Former Chemistry Director at Pfizer, Inc.

Relationship likelihood: Weak

Vice President, Preclinical Development at ONL Therapeutics, Inc.

Relationship likelihood: Weak

Chief Medical Officer at Kiniksa Pharmaceuticals Ltd.

Relationship likelihood: Weak

Former Vice President & Head-Global Cardiovascular Development at Amgen, Inc.

Relationship likelihood: Weak

Former Vice President & General Manager at Cardinal Health, Inc.

Relationship likelihood: Weak

Former Vice President-Development & Operations at Cerenis Therapeutics Holding SA

Relationship likelihood: Weak

Former Vice President-Pharmacology at AtheroGenics, Inc.

Relationship likelihood: Weak

Paths to Stephen Berezenko
Potential Connections via
Relationship Science
You
Stephen Berezenko
Former Vice President-Protein Manufacturing at Cerenis Therapeutics Holding SA
Career History
Research Director
Prior
Vice President-Protein Manufacturing
Prior

Cerenis Therapeutics Holding SA is a biopharmaceutical company, which engages in development of high density lipoprotein therapies for the treatment of cardiovascular and metabolic diseases. Its therapies consist of CER 001 and 209. The company was founded by Jean-Louis Dasseux on March 24, 2005 and is headquartered in Labege, France.

Other Affiliations

Stephen Berezenko is affiliated with Novozymes Biopharma AU Ltd., Cerenis Therapeutics Holding SA

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Stephen Berezenko. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Stephen Berezenko's profile does not indicate a business or promotional relationship of any kind between RelSci and Stephen Berezenko.